Barbara L. Asselin

Barbara L. Asselin, MD is a pediatric hospitalist at the Golisano Children's Hospital under the University of Rochester Medical Faculty Group, a certified provider network by the National Committee for Quality Assurance. She serves as a study investigator for the Children's Oncology Group and the Dana-Farber Leukemia Consortium, focusing on improving care for pediatric cancer patients.

• Medical Degree: University of Rochester School of Medicine/Dentistry (1981)
• Residency: University of Massachusetts Medical Center (1982-1984)
• Fellowship: University of Rochester Medical Center (1984-1987)

Her research focuses on clinical trials for pediatric cancers, particularly acute lymphoblastic leukemia (ALL) and non-Hodgkin lymphoma (NHL). Key areas include L-asparaginase pharmacology, cardioprotection in long-term survivors, and management of T-cell ALL/NHL. Recent publications analyze obesity impacts on ALL outcomes, minimal residual disease, and dexrazoxane's long-term cardiac effects.

• Scientific Awards: Best Doctors in America (2004-2014), Alpha Omega Alpha Medical Honor Society (2003-2010), George Washington Goler Associate Professor of Pediatrics (2002-2005)

Dr. Asselin's work has significantly influenced pediatric oncology treatment protocols, with emphasis on drug monitoring (e.g., asparaginase activity levels) and survivorship care. She contributes to educational initiatives for patients, families, and medical trainees.